e-therapeutics plc (LON:ETX – Get Free Report) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 11.36 ($0.14) and traded as low as GBX 9 ($0.11). e-therapeutics shares last traded at GBX 9 ($0.11), with a volume of 2,518,125 shares changing hands.
e-therapeutics Stock Down 6.7 %
The company has a market capitalization of £52.59 million, a P/E ratio of -450.00 and a beta of 0.46. The company has a current ratio of 22.20, a quick ratio of 20.13 and a debt-to-equity ratio of 0.33. The stock has a 50 day moving average price of GBX 9.19 and a 200 day moving average price of GBX 11.36.
About e-therapeutics
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.
Read More
- Five stocks we like better than e-therapeutics
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for e-therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
